Tirzepatide (Mounjaro) targets GLP-1 and GIP receptors with weight loss of approximately 20-22%
compounded semaglutide, youre not alone
Raben A, Andersen HB, Christensen NJ, Madsen J, Holst JJ, Astrup A
In the Novo case, he highlighted internal company statements that Novo had deliberately limited starter doses to avoid running out of higher maintenance doses later
A one-time purchase is great for those who want to try the product first before committing to a subscription
While plant- or animal-based protein options are the preferred choices for protein, protein shakes can be used if patients are struggling with reduced appetite or GI issues